UVM Awarded $1 Million Grant for Nicotine Research

MBF Bioscience >  Blog > MBF Products & Service Solutions  > Software & Microscope Integrated Systems  > Neurolucida®  > UVM Awarded $1 Million Grant for Nicotine Research


If you start smoking as a teen, it’s much harder to quit. University of Vermont Neurobiologist Rae Nishi wants to find out why. And thanks to a $1 million Challenge Grant, Nishi and her team will be able to further study the way adolescent brains react to nicotine.


The grant is one of 200 National Institute of Health grants allocated by the American Recovery and Reinvestment Act to help stimulate the American economy. These grants target projects involving health and science research. Dr. Nishi used this grant to purchase one of our Neurolucida workstations as well as products from another local Vermont company, Med Associates in St. Albans. The grant also helped fund three to four full-time research positions.


Read “Stimulus pumps up UVM research” at burlingtonfreepress.com to find out more about NIH Challenge Grants and Dr. Nishi’s research.

{Image of UVM senior Kelly Carstens, MBF Bioscience’s Geoff Greene, and Dr. Rae Nishi by Glenn Russell. Courtesy of Burlington Free Press}